Viewing Study NCT05726292


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2025-12-27 @ 5:46 AM
Study NCT ID: NCT05726292
Status: RECRUITING
Last Update Posted: 2025-02-10
First Post: 2023-02-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Sponsor: University of Chicago
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module